Use of the comprehensive in vitro proarrhythmia assay and in silico modeling to investigate the safety profile of bisphenol analogues

被引：0
|
作者：
Jaimes, Rafael [1 ]
McCullough, Damon [1 ]
Swift, Luther [1 ]
Reilly, Marissa [1 ]
Burke, Morgan [1 ]
Llopis Lorente, Jordi [2 ]
Trenor Gomis, Beatriz [2 ]
Saiz Rodriguez, Javier [2 ]
Sheng, Jiansong [3 ]
Posnack, Nikki G. [1 ]
机构：
[1] Childrens Natl Hlth Syst, Washington, DC USA
[2] Univ Politecn Valencia, Ci2B, Valencia, Spain
[3] CiPA Labs, Gaithersburg, MD USA
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2020年 / 105卷
关键词：
D O I：
10.1016/j.vascn.2020.106806
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
113
引用
收藏
页数：4
相关论文
共 49 条
  • [11] Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
    David G. Strauss
    Gary Gintant
    Zhihua Li
    Wendy Wu
    Ksenia Blinova
    Jose Vicente
    J. Rick Turner
    Philip T. Sager
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 519 - 525
  • [12] Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
    Strauss, David G.
    Gintant, Gary
    Li, Zhihua
    Wu, Wendy
    Blinova, Ksenia
    Vicente, Jose
    Turner, J. Rick
    Sager, Philip T.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (04) : 519 - 525
  • [13] Calculations of the binding free energies of the Comprehensive in vitro Proarrhythmia Assay (CiPA) reference drugs to cardiac ion channels
    Negami, Tatsuki
    Terada, Tohru
    BIOPHYSICS AND PHYSICOBIOLOGY, 2023, 20 (02)
  • [14] An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
    Crumb, William J., Jr.
    Vicente, Jose
    Johannesen, Lars
    Strauss, David G.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 251 - 262
  • [15] Regrettable substitution? Comparative study of the effect profile of bisphenol A and eleven analogues in an in vitro test battery
    Reininger, Natalie
    Oehlmann, Joerg
    ENVIRONMENTAL SCIENCES EUROPE, 2024, 36 (01)
  • [16] Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
    Yoon, Seung-Hyun
    Lee, Hyun-Lee
    Jeong, Da Un
    Lim, Ki Moo
    Park, Seong-Jun
    Kim, Ki-Suk
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [17] An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile
    Piper, Thomas
    Heimbach, Sonja
    Adamczewski, Martin
    Thevis, Mario
    DRUG TESTING AND ANALYSIS, 2021, 13 (05) : 916 - 928
  • [18] Use of an in vitro cytotoxicity assay to investigate the effects of chemicals used in the Gulf War
    Coliano, TH
    Eldefrawi, ME
    Eldefrawi, AT
    Valdes, JJ
    Azzazy, HME
    FASEB JOURNAL, 1999, 13 (04): : A155 - A155
  • [19] Modeling the Interaction of Binary Mixtures of Estradiol and Bisphenol A or Its Analogues in an In Vitro Estrogen Mediated Transcriptional Activation Assay (T47D-KBlue)
    Bermudez, Dieldrich Salomon
    Gray, L. Earl, Jr.
    Wilson, Vickie S.
    BIOLOGY OF REPRODUCTION, 2009, : 92 - 92
  • [20] Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti-seizure medication: Levetiracetam case study
    Delaunois, Annie
    Mathy, Francois-Xavier
    Cornet, Miranda
    Gryshkova, Vitalina
    Korlowski, Chloe
    Bonfitto, Francois
    Koch, Juliane
    Schlit, Anne-Francoise
    Hebeisen, Simon
    Passini, Elisa
    Rodriguez, Blanca
    Valentin, Jean-Pierre
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
12345